FDA Drug Safety Podcast: FDA warns that prescribing of Nizoral (ketoconazole) oral tablets for unapproved uses including skin and nail infections continues; linked to patient death
On May 19, 2016, FDA announced it is warning health care professionals to avoid prescribing the antifungal medicine ketoconazole oral tablets to treat skin and nail fungal infections. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - June 3, 2016 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
FDA Drug Safety Podcast: FDA warns about rare but serious skin reactions with mental health drug olanzapine (Zyprexa, Zyprexa Zydis, Zyprexa Relprevv, and Symbyax)
On May 10, 2016, the U.S. Food and Drug Administration (FDA) announced it is warning that the antipsychotic medicine olanzapine can cause a rare but serious skin reaction that can progress to affect other parts of the body. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - May 17, 2016 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
FDA Drug Safety Podcast: FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function
On April 8, 2016 FDA announced it is requiring labeling changes regarding the recommendations for metformin-containing medicines for diabetes to expand metformin’s use in certain patients with reduced kidney function. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - April 14, 2016 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
FDA Drug Safety Podcast: FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections
On December 4, 2015, FDA announced a safety review has resulted in adding warnings to the labels of a specific class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (SGLT2) inhibitors about the risks of ketoacidosis and of serious urinary tract infections (UTIs). Both conditions can result in hospitalization. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - March 30, 2016 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
FDA Drug Safety Podcast: FDA warns about several safety issues with opioid pain medicines; requires label changes
On March 22, 2016, FDA announced warnings about several safety issues with the entire class of opioid pain medicines. These safety risks are potentially harmful interactions with numerous other medications, problems with the adrenal glands, and decreased sex hormone levels. We are requiring changes to the labels of all opioid drugs to warn about these risks. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - March 30, 2016 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
TWiV 375: Zika and you will find
Hosts: Vincent Racaniello, Alan Dove, Rich Condit, and Kathy Spindler
Guests: Carolyn Coyne, Helen Lazear, and Jeremy Luban
The TWiVziks present everything you want to know about Zika virus, including association of infection with microcephaly and Guillain-Barré syndrome, transmission, epidemiology, and much more.
Links for this episode
Zika outbreak in Brazil (EID) 13:40
Zika summary (ProMedMail) 19:30
Zika and microcephaly (MMWR) 27:30
Facts about microcephaly (CDC)
Brazil Ministry of Health microcephaly numbers
Zika spread in Americas (MMWR)
Deu Zica 42:30
Microcephaly in Brazil (Lancet) 46:10
...
Source: This Week in Virology - MP3 Edition - February 7, 2016 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
FDA Drug Safety Podcast: FDA warns of serious liver injury risk with hepatitis C treatments Viekira Pak and Technivie
On October 22, 2015 FDA announced it is warning that hepatitis C treatments Viekira Pak and Technivie can cause serious liver injury mostly in patients with underlying advanced liver disease. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - October 30, 2015 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
Apr 17 Cardiology News
John Mandrola on monitoring new oral anticoagulants; the FDA's approval of Corlanor, review of cangrelor, and warning on diabetes drugs; leadless pacemaker; and electronic health records. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - April 17, 2015 Category: Cardiology Authors: Medscape Source Type: podcasts
Jane Pearson on Warning Signs for Childhood Suicide
Transcript (Source: NIMH Audio)
Source: NIMH Audio - November 4, 2014 Category: Psychiatry Authors: National Institute of Mental Health Source Type: podcasts
" Burn Notice " -- The Discovery Files
Stanford University scientists have developed a " smart " lithium-ion battery that gives ample warning before it overheats and bursts into flames. The new technology is designed for conventional lithium-ion batteries now used in billions of cellphones, laptops and other electronic devices, as well as a growing number of cars and airplanes. (Source: The Discovery Files)
Source: The Discovery Files - November 3, 2014 Category: Science Authors: National Science Foundation Source Type: podcasts
Adverse Events Caused by a Drug Warning?
Did the FDA's warning about suicidal behavior and antidepressant use in young people do more harm than good? (Source: Medscape Psychiatry Podcast)
Source: Medscape Psychiatry Podcast - July 31, 2014 Category: Psychiatry Authors: Medscape Source Type: podcasts
Hyponatremia: Don't Miss Subtle Clinical Clues
New guidelines suggest that asymptomatic hyponatremia doesn ' t really exist but that clinicians can identify and treat it if they know the warning signs. Dr. Jeffrey Berns discusses. (Source: Medscape Critical Care Podcast)
Source: Medscape Critical Care Podcast - May 2, 2014 Category: Intensive Care Authors: Medscape Source Type: podcasts
Hyponatremia: Don't Miss Subtle Clinical Clues
New guidelines suggest that asymptomatic hyponatremia doesn't really exist but that clinicians can identify and treat it if they know the warning signs. Dr. Jeffrey Berns discusses. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - May 2, 2014 Category: Endocrinology Authors: Medscape Source Type: podcasts
Lawn health warning: screen your lawn for Brown's Grass Disease and grasseoporosis
Last week I reported on taking my car to the doctor and how my doctor taught me that the car actually has certain automobile health diseases that need to be treated. I learned all about the big con of the prevention industry -- the people who change your oil and who flush out your transmission fluid and all these other con artists out there to try to "prevent" car problems. Thankfully my doctor completely reeducated me about the truth about automobile health. I thought "That's great. I learned so much from this guy. Let's talk to him about the health of my lawn." (Source: Health Ranger Report)
Source: Health Ranger Report - April 6, 2014 Category: Consumer Health News Source Type: podcasts
